Torrid Holdings stock price target cut to $2 by BofA on execution miss

Torrid Holdings (CURV) reported a Q3 EPS loss of $0.06 versus estimates of $0.02 (a roughly 200% negative surprise) and revenue of $235.2M versus $239.9M expected, prompting BofA to cut its price target to $2 from $6 while keeping a Buy. Management trimmed fiscal 2025 guidance to net sales of $995M–$1.002B (from $1.015B–$1.03B) and adjusted EBITDA to $59M–$62M (from $80M–$90M), citing execution misses and markdowns in tops; BofA now values fiscal 2026 at 6x EV/EBITDA (down from 9x). The print and guidance cut underline continued revenue pressure and margin compression, suggesting near-term downside for the equity despite BofA expecting a recovery in fiscal 2026.

Analysis

Market structure: Torrid’s miss and guidance cut transfer share and margin upside to larger, inventory‑efficient and off‑price players (TJX, ROST) while penalizing small specialty apparel chains and suppliers with concentrated exposure. The 5.8% trailing revenue decline, markdown-driven margin hit and BofA’s cut to a 6x FY26 EV/EBITDA multiple imply weaker pricing power and forced promotions into the next holiday season, raising retail volatility and implied vols for CURV options.

Risk assessment: Near term (days–weeks) expect elevated headline volatility and liquidity stress for CURV; medium term (weeks–months) holiday comps and inventory turns will determine whether EBITDA decays toward the revised $59–62m midpoint or stabilizes; long term (quarters) the call for a FY26 recovery is conditional on assortment fixes. Tail risks: covenant breach, accelerated inventory liquidation, or downgrade to penny‑stock status could occur within 6–12 months if cash flow weakens; hidden dependencies include vendor financing and credit-card chargebacks.

Trade implications: Tactical short bias is favored—low float, high downside but noisy rallies. Prefer 3–6 month puts or a modest outright short (1–2% net portfolio) with pair hedges into TJX/ROST or a CRM (Salesforce) long for defensive rotation. Time trades to post‑earnings reactions and holiday‑sales updates; use option spreads to cap downside.

Contrarian angles: The market may have over‑discounted FY26 recovery potential — valuation already embeds severe execution failure; a small asymmetric long via a 9–12 month call spread (caps downside) could pay off if assortment execution is fixed and comps normalize. Watch for short‑squeeze risk on any positive surprise given low absolute price and high short interest.

Key Decisions for Investors

• Establish a tactical 1–2% portfolio short position in CURV (ticker CURV) using 3–6 month 1.00 strike puts (or short shares if options illiquid). Target $0.60 cover, initial stop‑loss at $2.00; realize if company confirms FY26 EBITDA > mid‑point ($~60m) and sales guidance inflects higher.
• Implement a pair trade: short CURV (0.5–1% weight) and simultaneously add 1–2% long in TJX (ticker TJX) or ROST to capture off‑price share gains through Q1 FY2026; hold 6–12 months and reassess after holiday sales print.
• For asymmetric upside, buy a limited‑risk 9–12 month CURV call spread (buy 1.50 strike, sell 3.00 strike) sized to risk 0.25–0.5% of portfolio—max loss limited, upside if FY26 recovery materializes.
• Reallocate 3–5% away from small‑cap specialty apparel exposure into quality software and defensive retail: add 1–3% to CRM (Salesforce) and 1–2% to TJX/ROST to lower cyclical beta ahead of holiday demand clarity.
• Monitor over the next 30–60 days: (1) weekly same‑store sales and gross margin cadence vs. Torrid’s revised midpoints, (2) inventory days and markdown rate trends, and (3) liquidity metrics (cash + revolver availability and upcoming maturities). Use any deterioration vs. midpoints as a trigger to increase short size.